PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
Authors:
Open Access
- 23 March 2022
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Cardiovascular Medicine
- Vol. 9, 808929
Abstract
Being activated by endogenous and exogenous ligands, nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) enhances insulin sensitivity, promotes adipocyte differentiation, stimulates adipogenesis, and has the properties of anti-atherosclerosis, anti-inflammation, and anti-oxidation. The Human PPARγ gene (PPARG) contains thousands of polymorphic loci, among them two polymorphisms (rs10865710 and rs7649970) in the promoter region and two polymorphisms (rs1801282 and rs3856806) in the exonic region were widely reported to be significantly associated with coronary artery disease (CAD). Mechanistically, PPARG polymorphisms lead to abnormal expression of PPARG gene and/or dysfunction of PPARγ protein, causing metabolic disorders such as hypercholesterolemia and hypertriglyceridemia, and thereby increasing susceptibility to CAD.Keywords
This publication has 125 references indexed in Scilit:
- A synonymous polymorphic variation in ACADM exon 11 affects splicing efficiency and may affect fatty acid oxidationMolecular Genetics and Metabolism, 2013
- The Pro12Ala Polymorphism in the Peroxisome Proliferator-Activated Receptor Gamma-2 Gene (PPARγ2) Is Associated with Increased Risk of Coronary Artery Disease: A Meta-AnalysisPLOS ONE, 2012
- A Synonymous Single Nucleotide Polymorphism in ΔF508 CFTR Alters the Secondary Structure of the mRNA and the Expression of the Mutant ProteinJournal of Biological Chemistry, 2010
- Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicityHuman Genetics, 2010
- PPARγ gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitusCardiovascular Diabetology, 2010
- PPARγ Pro12Ala polymorphism and risk of acute coronary syndrome in a prospective study of DanesBMC Medical Genetics, 2009
- PPARγ Variant Influences Angiographic Outcome and 10-Year Cardiovascular Risk in Male Symptomatic Coronary Artery Disease PatientsDiabetes Care, 2009
- Peroxisome Proliferator‐Activated Receptor Gamma Polymorphisms and Coronary Heart DiseasePPAR Research, 2009
- Genetic Polymorphisms of Peroxisome Proliferator‐Activated Receptors and the Risk of Cardiovascular Morbidity and Mortality in a Community‐Based Cohort in Washington County, MarylandPPAR Research, 2007
- PPARγ gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expressionAmerican Heart Journal, 2007